Market Overview

Benzinga's Top Initiations

Share:

Analysts at UBS initiated coverage on shares of Kindred Healthcare (NYSE: KND) with a “neutral” rating. Kindred Healthcare's shares closed at $10.00 yesterday. Kindred Healthcare's PEG ratio is 0.71.

JP Morgan initiated coverage on shares of SXC Health Solutions (NASDAQ: SXCI) with an “overweight” rating. SXC Health Solutions' stock closed at $96.98 yesterday. SXC Health Solutions' trailing-twelve-month ROE is 15.49%.

Benchmark initiated coverage on shares of BioClinica (NASDAQ: BIOC) with a “buy” rating. BioClinica's shares closed at $4.80 yesterday. BioClinica's trailing-twelve-month revenue is $70.40 million.

Analysts at Roth Capital initiated coverage on shares of Standex International (NYSE: SXI) with a “neutral” rating. Standex International's shares closed at $42.89 yesterday. Standex International had $32.17 million in total cash for the latest quarter.

Latest Ratings for KND

DateFirmActionFromTo
Nov 2017Stifel NicolausUpgradesSellHold
Sep 2017Bank of AmericaMaintainsUnderperform
Aug 2017Deutsche BankMaintainsBuy

View More Analyst Ratings for KND
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (BIOC + KND)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
SNPSCFRAMaintains160.0
GRPNMorgan StanleyMaintains1.5
PPCCFRADowngrades30.0
HMSYCantor FitzgeraldReiterates33.0
FSLRCascendMaintains60.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com